Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

CAPS Rating: 2 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

Recs

0
Player Avatar srettun (< 20) Submitted: 1/23/2012 9:53:51 PM : Outperform Start Price: $47.00 JAZZ Score: -3.42

breaking out of cup and handle base

Featured Broker Partners


Advertisement